全文获取类型
收费全文 | 83145篇 |
免费 | 7682篇 |
国内免费 | 5369篇 |
专业分类
耳鼻咽喉 | 599篇 |
儿科学 | 995篇 |
妇产科学 | 1276篇 |
基础医学 | 9995篇 |
口腔科学 | 1586篇 |
临床医学 | 10580篇 |
内科学 | 12823篇 |
皮肤病学 | 885篇 |
神经病学 | 4561篇 |
特种医学 | 2872篇 |
外国民族医学 | 34篇 |
外科学 | 7939篇 |
综合类 | 13507篇 |
现状与发展 | 17篇 |
一般理论 | 12篇 |
预防医学 | 5663篇 |
眼科学 | 2163篇 |
药学 | 8980篇 |
95篇 | |
中国医学 | 4579篇 |
肿瘤学 | 7035篇 |
出版年
2024年 | 346篇 |
2023年 | 1342篇 |
2022年 | 3318篇 |
2021年 | 4223篇 |
2020年 | 3197篇 |
2019年 | 2693篇 |
2018年 | 2873篇 |
2017年 | 2604篇 |
2016年 | 2431篇 |
2015年 | 3697篇 |
2014年 | 4522篇 |
2013年 | 4232篇 |
2012年 | 6350篇 |
2011年 | 6674篇 |
2010年 | 4323篇 |
2009年 | 3389篇 |
2008年 | 4591篇 |
2007年 | 4390篇 |
2006年 | 4007篇 |
2005年 | 3899篇 |
2004年 | 2839篇 |
2003年 | 2565篇 |
2002年 | 2312篇 |
2001年 | 1878篇 |
2000年 | 1968篇 |
1999年 | 2054篇 |
1998年 | 1318篇 |
1997年 | 1301篇 |
1996年 | 1007篇 |
1995年 | 981篇 |
1994年 | 801篇 |
1993年 | 493篇 |
1992年 | 572篇 |
1991年 | 519篇 |
1990年 | 441篇 |
1989年 | 387篇 |
1988年 | 308篇 |
1987年 | 311篇 |
1986年 | 237篇 |
1985年 | 187篇 |
1984年 | 124篇 |
1983年 | 84篇 |
1982年 | 62篇 |
1981年 | 47篇 |
1980年 | 33篇 |
1979年 | 44篇 |
1978年 | 18篇 |
1974年 | 17篇 |
1973年 | 17篇 |
1966年 | 18篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
101.
102.
医院融资经营提高资本利用质量 总被引:1,自引:0,他引:1
着重从资本运作中最主要的手段——融资,去剖析医院以融资方式实现医疗规模迅速扩张的全过程。介绍了经营租赁与融资租赁及其优缺点,并附案例加以说明。 相似文献
103.
松花粉对人肺成纤维细胞增殖活性影响的实验研究 总被引:1,自引:0,他引:1
目的 :研究松花粉对人肺成纤维细胞增殖的影响 ,探讨中药松花粉可能的作用机理。方法 :松花粉作用于人肺成纤维细胞不同时间后观察细胞生长速度 ,应用台盼蓝对细胞进行染色 ,测定细胞死亡率。松花粉浓度分别为 10 0、2 0 0、40 0、80 0mg·L-1,以未经松花粉处理的细胞为对照。结果 :松花粉作用于人肺成纤维细胞能够明显促进细胞群体倍增水平 ,降低死亡细胞数目 ,且呈剂量依赖关系。结论 :松花粉可通过促进细胞生长而影响细胞增殖。 相似文献
104.
人白细胞介素12双亚基共表达真核载体的构建 总被引:2,自引:0,他引:2
目的:为满足基因治疗的需要构建人白细胞介素12(hIL-12)双亚基共表达质粒。方法:先从人胚肾组织的逆转录产物中用PCR方法扩增出它的两个亚基P40和P35的cDNA全长,分别克隆入真核表达载体pcDNA3.1( /-)中构建单亚基质粒——P( )/P40和P(-)/P35,然后再将二者串联克隆入真核表达载体poDNA3.1( )中得到P( )/IL-12质粒。脂质体转染HepG2后24,48h ELISA检测细胞培养上清内hIL-12蛋白质表达。结果:P( )/IL-12质粒经酶切和测序证明两亚基连接方向正确,序列无突变;ELISA检测细胞上清结果证实可表达hIL-12蛋白质。结论:成功构建P40和P35双亚基真核共表达质粒——P( )/IL-12,为模拟hIL-12生理表达方式,简化hIL-12基因治疗操作奠定了基础。 相似文献
105.
Chih-Ming Lin Pei-Chen Lee Sen-Wen Teng Tsung-Hsueh Lu I-Fang Mao Chung-Yi Li 《台湾医志》2004,103(4):297-301
BACKGROUND AND PURPOSE: Birth certificates are a major source of population-based data often used in maternal and child health research, but their value depends upon the level of accuracy of the data. The purpose of this study was to assess the validity of the birth registry data in Taiwan. METHODS: Obstetric records of a total of 2779 infants born at a municipal hospital in Taipei between 1995 and 1997 were abstracted and linked to the Taiwan Birth Registry (TBR). Concordance was presented by agreement percentages for various birth characteristics including gender, birth order, birth weight, and gestational age. Concordance was further assessed using Cohen's k and sensitivity/specificity for both birth weight and gestational age, with both variables categorized according to their customary definitions. RESULTS: Missing data for specific items in the TBR ranged from 0% (gender) to 1.6% (birth order). The birth registry accurately reported all 4 selected items, with the highest and lowest concordance percentage noted for gender (99.0%) and gestational age (88.3%), respectively. The level of agreement indicated by the Cohen's k statistic ranged from 0.92 to 0.96 for birth weight and gestational age when both variables were treated as categorical variables. CONCLUSIONS: The TBR showed a low rate of missing information and high levels of validity for the elements frequently used in maternal and child health research in Taiwan. 相似文献
106.
Raquel Carreira Ana Duarte Pedro Monteiro Maria Sancha Santos Ana Cristina Rego Catarina R Oliveira Lino M Gon?alves Luís A Providência 《Revista portuguesa de cardiologia》2004,23(11):1447-1455
Ischemia negatively affects mitochondrial function by inducing the mitochondrial permeability transition (MPT). The MPT is triggered by oxidative stress, which occurs in mitochondria during ischemia as a result of diminished antioxidant defenses and increased reactive oxygen species production. It causes mitochondrial dysfunction and can ultimately lead to cell death. Therefore, drugs able to minimize mitochondrial damage induced by ischemia may prove to be clinically effective. We analyzed the effect of carvedilol, a beta-blocker with antioxidant properties, on mitochondrial dysfunction. Carvedilol decreased levels of TBARS (thiobarbituric acid reactive substances), an indicator of oxidative stress, which is consistent with its antioxidant properties. Regarding cell death by apoptosis, although ischemia did increase caspase-8-like activity, there were no changes in caspase-3-like activity, which is activated downstream of caspase-8; this may indicate that the apoptotic cascade is not activated by 60 minutes of ischemia. We conclude that carvedilol protects ischemic mitochondria by preventing oxidative mitochondrial damage, and, by so doing, it may also inhibit the formation of the MPT pore. 相似文献
107.
桂枝镇痛效应的药理学研究 总被引:2,自引:0,他引:2
目的 探讨桂枝的镇痛作用。方法 采用热板法和扭体法观察该药的镇痛作用。结果 桂枝对小鼠热致痛和醋酸致痛均有明显的抗痛作用 ,与颅痛定镇痛效果比较均无显著差异 (P >0 .0 5 ) 。结论 桂枝具有镇痛效应 ,对临床应用、镇痛药开发具有借鉴和指导意义。 相似文献
108.
109.
S Lu D D Parekh O Kuznetsova S A Green C A Tozzi T F Reiss 《The European respiratory journal》2006,28(4):772-780
Cholinergic antagonists have been used since the early 1900s as bronchodilators for chronic obstructive pulmonary disease (COPD). The present study investigated whether an oral muscarinic M3-selective anticholinergic agent (OrM3) would provide an improved therapeutic advantage compared with an inhaled anticholinergic agent in patients with COPD. A 6-week, multicentre, randomised, placebo- and active-controlled, parallel-group study was performed at 56 sites in the USA. In total, 412 male and female patients (aged 35-86 yrs) with a clinical history consistent with COPD were randomised to receive OrM3 0.5, 2, 3 or 4 mg orally once daily, ipratropium bromide 36 mug by inhalation four times daily or placebo. OrM3 demonstrated a significant dose-related improvement in serial forced expiratory volume in one second and a trend for dose-related improvement in patient-reported symptoms compared with placebo. However, at a dose that provided efficacy less than that of ipratropium, the incidence of dose-related, mechanism-based side-effects for OrM3 exceeded those observed for ipratropium. In patients with chronic obstructive pulmonary disease, the oral M3-selective agent did not offer a therapeutic advantage over inhaled ipratropium. These results do not support the hypothesis that high selectivity for muscarinic M3 receptors over airway neuronal M2 receptors will represent a more effective therapy than current inhaled anticholinergics in obstructive airway disease. 相似文献
110.
Yan Wang Xuesong Zhang Songhua Xiao Ning Lu Zheng Wang Mi Zhou 《Journal of orthopaedic surgery and research》2006,1(1):13-7